Johnson & Johnson as of June 30, 2025
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 20 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 40.8 | $136M | 2.4M | 55.69 | |
| Meiragtx Holdings (MGTX) | 13.1 | $44M | 6.6M | 6.61 | |
| Rapport Therapeutics (RAPP) | 8.5 | $29M | 2.5M | 11.43 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 8.4 | $28M | 815k | 34.63 | |
| Nanobiotix Sponsored Ads (NBTX) | 7.6 | $26M | 5.6M | 4.53 | |
| CVRX (CVRX) | 7.1 | $24M | 4.1M | 5.82 | |
| Procept Biorobotics Corp (PRCT) | 6.1 | $20M | 358k | 56.91 | |
| Contineum Therapeutics Cl A (CTNM) | 2.4 | $8.1M | 2.0M | 4.11 | |
| Xencor (XNCR) | 1.8 | $6.1M | 748k | 8.14 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $4.0M | 248k | 16.08 | |
| Fate Therapeutics (FATE) | 1.1 | $3.5M | 3.4M | 1.04 | |
| Neumora Therapeutics (NMRA) | 0.4 | $1.4M | 1.8M | 0.76 | |
| Rallybio Corp (RLYB) | 0.4 | $1.2M | 3.6M | 0.33 | |
| Vor Biopharma | 0.3 | $1.1M | 1.1M | 1.06 | |
| Nano-X Imaging Ord Shs (NNOX) | 0.2 | $831k | 159k | 5.23 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $371k | 312k | 1.19 | |
| Lyell Immunopharma | 0.1 | $368k | 41k | 8.94 | |
| Adicet Bio | 0.1 | $228k | 365k | 0.63 | |
| Chardan Healthcare Acqu- Ord | 0.0 | $43k | 97k | 0.44 | |
| Senseonics Hldgs | 0.0 | $27k | 55k | 0.49 |
